The vascular endothelial growth factor (VEGF) family, the regulator of blood and lymphatic
vessels, is mostly investigated in the tumor and ophthalmic field. However, the functions it …

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive and devastating interstitial
lung disease of unknown etiology, where the normal lung architecture is lost and replaced …

The vascular endothelial growth factor (VEGF) family, the crucial regulator of angiogenesis,
lymphangiogenesis, lipid metabolism and inflammation, is involved in the development of …

Idiopathic pulmonary fibrosis (IPF) is a worldwide disease characterized by the chronic and
irreversible decline of lung function. Currently, there is no drug to successfully treat the …

The transforming growth factor-beta (TGF-β) signaling pathway is a vital regulator of cell
proliferation, differentiation, apoptosis, and extracellular matrix production. It functions …

The impact of lipotoxicity on the development of lung fibrosis is unclear. Saturated fatty
acids, such as palmitic acid (PA), activate endoplasmic reticulum (ER) stress, a cellular …

BACKGROUND Homozygous deletion of 9p21 detected by fluorescence in situ hybridization
(FISH) and loss of BRCA1‐associated protein 1 (BAP1) expression detected by …

Lymphatic vessels drain excess tissue fluids to maintain the interstitial environment.
Lymphatic capillaries develop during the progression of tissue fibrosis in various clinical and …

The characteristic features of chronic peritoneal injury with peritoneal dialysis (PD) are
submesothelial fibrosis and neoangiogenesis. Transforming growth factor (TGF) β and …

Blood vessels and lymphatic vessels are located in many tissues and organs throughout the
body, and play important roles in a wide variety of prevalent diseases in humans. Vascular …